Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

(2020) Ignacio J. Ansotegui et al.   World Allergy Organization Journal

Algorithms in allergen immunotherapy in allergic rhinoconjunctivitis

(2020) Oliver Pfaar et al.   ALLERGY

Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen

(2020) David Larson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs

(2020) O. Pfaar et al.   Clinical and Translational Allergy

Perspectives in allergen immunotherapy: 2019 and beyond

(2019) Oliver Pfaar et al.   ALLERGY

Clinical trials in allergen immunotherapy: current concepts and future needs

(2018) O. Pfaar et al.   ALLERGY

Perspectives in allergen immunotherapy: 2017 and beyond

(2018) O. Pfaar et al.   ALLERGY

Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial

(2018) R. Mösges et al.   ALLERGY

Conjunctival provocation tests

(2018) Julian Schröder et al.   Current Opinion in Allergy and Clinical Immunology

Treatment with grass allergen peptides improves symptoms of grass pollen–induced allergic rhinoconjunctivitis

(2017) Anne K. Ellis et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis

(2016) Maria Kristiansen et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy

(2016) Petra Zieglmayer et al.   EBioMedicine

Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research

(2015) Michelle L. North et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needs

(2015) Karen Rösner-Friese et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

International consensus on allergy immunotherapy

(2015) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Conjunctival Provocation Tests: A Predictive Factor for Patients' Seasonal Allergic Rhinoconjunctivitis Symptoms

(2015) Kristian Kruse et al.   Journal of Allergy and Clinical Immunology-In Practice

Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure

(2014) S. R. Durham et al.   ALLERGY

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

(2014) O. Pfaar et al.   ALLERGY

Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber

(2013) W. Meyer et al.   ALLERGY

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy

(2013) V. Baron-Bodo et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Allergen-specific CD4+T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy

(2012) M. Bonvalet et al.   CLINICAL AND EXPERIMENTAL ALLERGY

A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy

(2012) Aline Zimmer et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients

(2011) P. Howarth et al.   ALLERGY

Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy

(2011) L. Van Overtvelt et al.   ALLERGY

Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season

(2011) Philipp Badorrek et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen

(2011) Robert L. Jacobs et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Can Immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen?

(2011) J. Huss-Marp et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Evaluating the Effects of Testing Period on Pollinosis Symptoms Using an Allergen Challenge Chamber

(2011) Ayumi Yuki et al.   ALLERGOLOGY INTERNATIONAL

The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy

(2010) P. Devillier et al.   ALLERGY

Factors that affect the allergic rhinitis response to ragweed allergen exposure

(2010) Anne K. Ellis et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

(2009) H-J. Malling et al.   CLINICAL AND EXPERIMENTAL ALLERGY

The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber

(2009) Friedrich Horak et al.   INFLAMMATION RESEARCH